Ready to refill
Tirzepatide (Zepbound) falls in a similar range
Komagata D et al
Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells
These are valid concerns, especially for women depending on medication weight loss solutions for steady results
:max_bytes(150000):strip_icc()/GettyImages-1393991964-5452e32871e7431493115521bb14ae22.jpg)
Volume Stages Pilot 500-1,000 units For: formula lock, Amazon/DTC test, pack check Gate: liposome integrity / GSH/GSSG retention / sensory / seal integrity First commercial 5,000-10,000 units For: regional / e-comm launch Gate: batch reproducibility / pack-line validation / accelerated stability Note: qualified private-label entry commonly starts around 3,000-5,000 units depending on format Full-scale 100,000+ units For: retail / export programs Gate: sourcing continuity / cost structure / QC reproducibility across reorders Format MOQ & Lead Time (Confirm Per Project) Capsules: from 5,000 units / 4-6 weeks Softgels: from 10,000 units / 5-7 weeks Stick packs: from 10,000 units / 5-7 weeks Gummies: from 10,000 units / 6-8 weeks Liquids: project-scoped / typically 5-8 weeks after formula lock What Moves Price Beyond MOQ GSH grade and dose / phospholipid system / encapsulation depth / barrier packaging / contaminant panel / rush schedule / multi-market label packs What Moves Scale Timing Sell-through data / regional clearance status/phospholipid and GSH availability/channel expansion needs Predictable cycle with exit criteria at each gate
